Entrada Therapeutics Inc
NASDAQ:TRDA
Cash Flow Statement
Cash Flow Statement
Entrada Therapeutics Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||
Net Income |
(34)
|
(41)
|
(51)
|
(73)
|
(78)
|
(89)
|
(95)
|
(80)
|
(82)
|
(22)
|
(7)
|
|
Depreciation & Amortization |
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
212
|
197
|
159
|
140
|
|
Stock-Based Compensation |
1
|
1
|
3
|
4
|
6
|
8
|
10
|
11
|
11
|
12
|
0
|
|
Other Non-Cash Items |
1
|
1
|
3
|
5
|
7
|
9
|
10
|
11
|
9
|
8
|
7
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
Change in Working Capital |
4
|
2
|
(3)
|
(5)
|
(4)
|
(9)
|
(11)
|
(14)
|
(13)
|
(32)
|
(4)
|
|
Cash from Operating Activities |
(29)
N/A
|
(37)
-30%
|
(51)
-37%
|
(72)
-41%
|
(74)
-3%
|
(87)
-18%
|
(94)
-8%
|
131
N/A
|
114
-13%
|
117
+3%
|
140
+20%
|
|
Investing Cash Flow | ||||||||||||
Capital Expenditures |
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
|
Other Items |
0
|
0
|
0
|
(181)
|
(156)
|
(165)
|
(146)
|
(4)
|
(140)
|
(133)
|
(133)
|
|
Cash from Investing Activities |
(4)
N/A
|
(5)
-12%
|
(5)
+3%
|
(186)
-3 963%
|
(159)
+14%
|
(169)
-6%
|
(149)
+12%
|
(8)
+95%
|
(145)
-1 809%
|
(139)
+4%
|
(138)
+0%
|
|
Financing Cash Flow | ||||||||||||
Net Issuance of Common Stock |
142
|
117
|
307
|
308
|
191
|
191
|
0
|
20
|
20
|
21
|
21
|
|
Cash from Financing Activities |
142
N/A
|
117
-17%
|
307
+163%
|
308
+0%
|
191
-38%
|
191
0%
|
0
-100%
|
20
+4 046%
|
20
+3%
|
21
+1%
|
21
+2%
|
|
Change in Cash | ||||||||||||
Net Change in Cash |
109
N/A
|
75
-31%
|
252
+235%
|
50
-80%
|
(42)
N/A
|
(65)
-54%
|
(242)
-273%
|
143
N/A
|
(11)
N/A
|
(2)
+87%
|
22
N/A
|
|
Free Cash Flow | ||||||||||||
Free Cash Flow |
(33)
N/A
|
(42)
-28%
|
(55)
-33%
|
(77)
-39%
|
(77)
0%
|
(91)
-17%
|
(97)
-7%
|
127
N/A
|
109
-14%
|
111
+2%
|
134
+21%
|